title: Effect of cholesterol on the properties of spray-dried lysozyme-loaded liposomal powders.
abstract: The influence of cholesterol (Chol) in the liposomal bilayer on the properties of inhalable protein-loaded liposomal powders prepared by spray-drying technique was investigated. Lysozyme (LSZ) was used as a model protein. Feed solution for spray drying was prepared by direct mixing of aqueous solution of LSZ with mannitol solution and empty liposome dispersions composed of hydrogenated phosphatidylcholine and Chol at various molar ratios. The spray-dried powders were characterized with respect to morphology, thermal property, and crystallinity using scanning electron microscopy, differential scanning calorimetry, and X-ray diffraction, respectively. Most formulations gave slightly aggregated, spherical particles, and percentage yields of the spray-dried powders decreased with increasing Chol content. Degree of particle aggregation depended on the powder composition. The powders spontaneously formed liposomes which efficiently entrapped LSZ after reconstitution with HEPES buffered saline (HBS) at 37 degrees C. Lysozyme entrapment efficiency and size distribution of the reconstituted liposomes were evaluated after the powders were reconstituted with HBS. Increasing Chol content resulted in a decrease in size of the reconstituted liposomes and an increase in entrapment efficiency of LSZ. These results correlated with thermal behaviors of the reconstituted liposomes. Biological activity of LSZ was not affected by the spray-drying process. It was also demonstrated that LSZ-loaded liposomal powders could be produced without the need to preload the LSZ into liposomes prior to spray-drying process.
authors.affiliation: Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand.
authors.forename: Dusadee
authors.initials: D
authors.lastname: Charnvanich
authors.forename: Nontima
authors.initials: N
authors.lastname: Vardhanabhuti
authors.forename: Poj
authors.initials: P
authors.lastname: Kulvanich
mesh_terms: D000042:Absorption; D002784:Cholesterol / Q000737:chemistry*; D004337:Drug Carriers / Q000737:chemistry*; D004339:Drug Compounding / Q000379:methods; D004795:Enzyme Stability; D005079:Excipients / Q000737:chemistry*; D005740:Gases / Q000737:chemistry; D008081:Liposomes / Q000737:chemistry*; D008837:Micrococcus / Q000378:metabolism*; D009113:Muramidase / Q000737:chemistry* / Q000493:pharmacokinetics*; D011208:Powders
chemical_list: D004337:Drug Carriers; D005079:Excipients; D005740:Gases; D008081:Liposomes; D011208:Powders; D002784:Cholesterol; D009113:Muramidase
references.citation: J Colloid Interface Sci. 2003 Feb 15;258(2):335-44
references.pmid: 12618103
references.citation: Drug Dev Ind Pharm. 2000 Dec;26(12):1279-84
references.pmid: 11147128
references.citation: J Control Release. 2004 Feb 10;94(2-3):259-72
references.pmid: 14744478
references.citation: J Liposome Res. 2005;15(3-4):157-66
references.pmid: 16393907
references.citation: AAPS J. 2005 Mar 24;7(1):E20-41
references.pmid: 16146340
references.citation: J Pharm Sci. 2002 Feb;91(2):482-91
references.pmid: 11835207
references.citation: Am J Physiol. 1995 Mar;268(3 Pt 1):L374-80
references.pmid: 7900818
references.citation: Biophys J. 2007 Jul 1;93(1):140-53
references.pmid: 17434939
references.citation: Eur J Pharm Biopharm. 2007 Nov;67(3):655-66
references.pmid: 17540552
references.citation: AAPS PharmSciTech. 2008;9(1):47-53
references.pmid: 18446460
references.citation: Biochim Biophys Acta. 2005 Jul 15;1713(1):57-64
references.pmid: 15950174
references.citation: Pharm Res. 1992 Apr;9(4):515-20
references.pmid: 1495897
references.citation: Eur J Pharm Biopharm. 2006 May;63(1):51-8
references.pmid: 16380243
references.citation: Biochim Biophys Acta. 1952 Mar;8(3):302-9
references.pmid: 14934741
references.citation: Biochemistry. 1987 Aug 25;26(17):5389-97
references.pmid: 3676258
references.citation: J Control Release. 2006 Jun 12;113(1):9-14
references.pmid: 16730838
references.citation: Biophys J. 2007 Aug 15;93(4):1204-14
references.pmid: 17526577
references.citation: J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):3001-9
references.pmid: 17048511
references.citation: Int J Pharm. 1999 Jun 25;183(2):185-93
references.pmid: 10361169
references.citation: Int J Pharm. 2004 Feb 11;270(1-2):297-306
references.pmid: 14726144
references.citation: Biochim Biophys Acta. 1976 Oct 26;457(2):109-32
references.pmid: 184844
references.citation: Adv Drug Deliv Rev. 2006 Oct 31;58(9-10):1009-29
references.pmid: 17005293
references.citation: J Control Release. 2000 Jul 31;68(1):85-95
references.pmid: 10884582
references.citation: Biochim Biophys Acta. 1988 Jun 9;947(2):367-84
references.pmid: 3285894
references.citation: Pharm Res. 1997 Sep;14(9):1151-60
references.pmid: 9327441
references.citation: Adv Drug Deliv Rev. 1997 Jun 9;26(1):51-58
references.pmid: 10837532
references.citation: Biochemistry. 1993 Jan 19;32(2):516-22
references.pmid: 8422361
references.citation: Int J Pharm. 2002 Oct 24;247(1-2):79-90
references.pmid: 12429487
references.citation: J Biol Chem. 1959 Mar;234(3):466-8
references.pmid: 13641241
references.citation: Eur J Pharm Biopharm. 2008 May;69(1):83-93
references.pmid: 18166446